Petros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra® Prescription Erectile Dysfunction Medication to Achieve Designation as an Over-the-Counter Treatment

July 13, 2021

Splash Beverage Group Announces Its Initial Closing on the First Tranche of Private Placement

August 22, 2024
Splash Beverage Group Secures Statewide Authorization for SALT Naturally Flavored Tequila in Pennsylvania

July 18, 2024
Splash Beverage Group Appoints Dr. John Paglia, a Professor of Finance at Pepperdine Graziadio Business School, to Its Board of Directors

March 1, 2024
Splash Beverage Group Extends Copa di Vino’s Retail Sales Presence with Iconic Las Vegas Retailer

February 20, 2024